Patent · US Active

Compounds for use in the treatment of conditions associated with NADPH oxidase

US10195167B2 · kind B2 · utility

1Cited by

0References

17Claims

0Family size

Assignee

GLUCOX BIOTECH AB · SE

Inventors

Per Wikström · Uppsala, SE
Erik Walum
Mona Wilcke · Stockholm, SE

Key dates

Filing date	Dec 14, 2015
Grant date	Feb 5, 2019
Priority date	—
Expiry date	Jan 27, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of formula (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of a condition or disorder associated with nicotinamide adenine dinucleotide phosphate oxidase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.